Issue 2/2020
Special Issue: Current aspects of neuropsychiatry: An appreciation of Prof. Dr. Moussa B.H. Youdim on the occasion of his 80th birthday
Content (20 Articles)
Prof. Dr. Moussa B.H. Youdim: an appreciation on the occasion of his 80th birthday
Peter Riederer
Ted Sourkes, Moussa Youdim and I
A. Claudio Cuello
The discovery and development of rasagiline as a new anti-Parkinson medication
John P. M. Finberg
Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease
Makoto Naoi, Wakako Maruyama, Masayo Shamoto-Nagai
Microglia and Parkinson's disease: footprints to pathology
Ekaterina Lazdon, Nofar Stolero, Dan Frenkel
The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson’s disease and in schizophrenia
Dorit Ben-Shachar
The catecholaldehyde hypothesis: where MAO fits in
David S. Goldstein
Parkinson’s disease and iron
Hideki Mochizuki, Chi-Jing Choong, Kousuke Baba
Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
David Devos, Z. Ioav Cabantchik, Caroline Moreau, Véronique Danel, Laura Mahoney-Sanchez, Hind Bouchaoui, Flore Gouel, Anne-Sophie Rolland, James A. Duce, Jean-Christophe Devedjian, Julien Cassereau, Marie Bost, Charlotte Abrial, Jeanne Muller, Audrey Olivier, Gwendal Le Masson, Stéphane Mathis, Dieynaba Djigo, Sarah Bonabaud, Mathilde Deloire, Steeve Genestet, Elsa Menanteau, Pauline Bourgeois, Mathilde Lefilliatre, Fausto Viader, Mouloud Abrou, Damien Chavanne, Rachida Bari, Nathalie Guy, Sophia Sickout Arondo, Sandrine Rouvet, Katell Beauvais, Mathilde Aidan, Olivier Madec, Veronique Danel-Brunaud, Celine Tard, Marie Pleuvret, Valerie Santraine, Julie Moutarde, Philippe Couratier, Géraldine Lautrette, Selma Machat, Marie Penoty, Olivier Villeneuve, Clémence Labetoulle, Julie Catteau, Emilien Bernard, Juliette Svahn, Camille Neuillet, Shahram Attarian, Aude-Marie Grapperon, Annie Verschueren, Amandine Parlanti, Nacime Heddadji, William Camu, Sophie Pittion-Vouyovitch, Maud Michaud, Anne Chatelain, Isabelle Costa, Marie-Hélène Soriani, Arnaud Declemy, Carole Barre, François Salachas, Ivan Kolev, Jean-Christophe Antoine, Jean-Philippe Camdessanche, Nathalie Dimier, Karine Ferraud, Vincent Visneux, Marie-Cécile Fleury, Pascal Cintas, Blandine Acket, Magali Centelles, Véronique Hermet, Philippe Corcia, Stephane Beltran, Salah Bakkouche
Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy
Micaela Johanna Glat, Nadia Stefanova, Gregor Karl Wenning, Daniel Offen
6-Hydroxydopamine: a far from simple neurotoxin
Damir Varešlija, Keith F. Tipton, Gavin P. Davey, Andrew G. McDonald
Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
Jelena Osmanovic Barilar, Ana Knezovic, Ana Babic Perhoc, Jan Homolak, Peter Riederer, Melita Salkovic-Petrisic
Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond
Oxana Kapitansky, Eliezer Giladi, Iman Jaljuli, Stefan Bereswill, Markus M. Heimesaat, Illana Gozes
Different response to instrumental tests in relation to cognitive demand after dopaminergic stimulation in previously treated patients with Parkinson’s disease
Thomas Müller, Ali Harati
Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson’s disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?
Toshiharu Nagatsu
Cannabinoid1 (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose
Phil Skolnick, Roger Crystal
FG 7142: is this validated tool to study anxiety now forgotten?
R. Horowski
A platinum black-modified microelectrode for in situ olanzapine detection in microliter volumes of undiluted serum
Rajendra P. Shukla, Robert H. Belmaker, Yuly Bersudsky, Hadar Ben-Yoav